These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 6106520)
41. [Chlorbutin, azathioprine, d-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis patients. III. A comparative analysis of their effect on the morphological manifestations of synovitis based on puncture biopsy data]. Shekhter AB; Krel' AA; Chichasova NV; Rashchupkina ZP Ter Arkh; 1984; 56(2):121-31. PubMed ID: 6710393 [No Abstract] [Full Text] [Related]
43. A comparison of low dose levamisole and penicillamine in rheumatoid arthritis. Clemens LE; Ansell BM; Bernstein RM; Hall MA; McCauley D Aust N Z J Med; 1983 Dec; 13(6):578-82. PubMed ID: 6586147 [TBL] [Abstract][Full Text] [Related]
44. "Disease-modifying" drugs in rheumatoid arthritis. Drug Ther Bull; 1985 Dec; 23(26):101-4. PubMed ID: 2866082 [No Abstract] [Full Text] [Related]
45. How do second-line agents work? Choy E; Kingsley G Br Med Bull; 1995 Apr; 51(2):472-92. PubMed ID: 7552077 [TBL] [Abstract][Full Text] [Related]
46. The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis. Paulus HE Arthritis Rheum; 1990 Jan; 33(1):113-20. PubMed ID: 1967942 [No Abstract] [Full Text] [Related]
47. [Therapy of inflammatory and degenerative joint diseases]. Chlud K Wien Med Wochenschr; 1980; 130 Spec No():12-27. PubMed ID: 6256979 [No Abstract] [Full Text] [Related]
48. Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole. Mowat AG Ann Rheum Dis; 1978 Feb; 37(1):1-8. PubMed ID: 629595 [TBL] [Abstract][Full Text] [Related]
49. [Differential indications in rheumatism therapy on the basis of well-known drug side effects]. Mathies H Acta Med Austriaca; 1975; 2(4):156-60. PubMed ID: 1224932 [TBL] [Abstract][Full Text] [Related]
50. Clinical aspects: specificity and mode of action of immunosuppressives. Currey HL Rheumatol Rehabil; 1976 Aug; 15(3):221-3. PubMed ID: 9683 [No Abstract] [Full Text] [Related]
51. [Operative treatment of rheumatoid arthritis and its radiography]. Wessinghage D; Kroeger FJ; Albers P; Weigand H Radiologe; 1973 Jun; 13(6):250-64. PubMed ID: 4730744 [No Abstract] [Full Text] [Related]
56. An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of today. Paulus HE Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):26-9. PubMed ID: 7065739 [TBL] [Abstract][Full Text] [Related]
57. [DNA-synthesizing lymphocytes in the blood of patients with disseminated lupus erythematosus, rheumatoid arthritis, and panarteritis nodosa (author's transl)]. Huber C; Günther R; Michlmayr G; Huber H; Braunsteiner H Wien Klin Wochenschr; 1973 Feb; 85(6):92-5. PubMed ID: 4155172 [No Abstract] [Full Text] [Related]
58. Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods. Situnayake RD; Grindulis KA; McConkey B Ann Rheum Dis; 1987 Mar; 46(3):177-83. PubMed ID: 2883939 [TBL] [Abstract][Full Text] [Related]
59. [Rheumatoid arthritis. Considerations on a rational therapeutic strategy]. Tarocco RP; Faro G; Michelotti A; Sargiotto A Minerva Med; 1984 Feb; 75(8):363-74. PubMed ID: 6369174 [TBL] [Abstract][Full Text] [Related]
60. Pharmacological studies of antigen-induced arthritis in BALB/c mice. II. The effects of second-line antirheumatic drugs and cytotoxic agents on the histopathological changes. Hunneyball IM; Crossley MJ; Spowage M Agents Actions; 1986 Jun; 18(3-4):394-400. PubMed ID: 2875633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]